On April 8, 2024, a once-in-a-lifetime total solar eclipse kept the eyes of millions of Quebecers riveted on the sky. But the ...

For people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have ...

With myopia cases predicted to impact nearly half the world’s population by 2050, Dr Bindiya Hapani highlights how screen ...

Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.

Exclusion criteria included history of trauma, history of severe eye infections or inflammatory disease, diabetic retinopathy ... SO was used for retinal detachment. If a patient was required to ...

Ocugen's drug to treat retina diseases received a rare pediatric disease designation from U.S. regulators. The biotechnology said Tuesday that the Food and Drug Administration granted the designation ...

The objective of this study was to report a case of bilateral hypertensive retinopathy in a female child with chronic renal disease caused by focal segmental ... Fundoscopic examination showed ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

It will grow to $2.98 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. ” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The ...

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...

Vascular endothelial growth factor (VEGF) stimulates breakdown of blood-retinal barrier that causes accumulation of fluid within macula. Anti-VEGF therapy is the first-line treatment for both the ...